Abstract
Asphyxiated neonates often have hypotension, shock and poor tissue perfusion. Various inotropic medications are commonly used to provide the cardiovascular support to improve the blood pressure and to treat shock. However, there is a paucity of literature on the systemic and regional hemodynamic effects of these inotropic medications in asphyxiated neonates, necessitating cautious translation of findings from other clinical populations and animal studies. This review discusses the current available information, from both clinical studies and animal models of neonatal asphyxia, on commonly used mediations including dopamine, dobutamine, epinephrine, milrinone, levosimendan and hydrocortisone.
Keywords: Newborn, asphyxia, inotropes, catecholamines, blood pressure
Current Pediatric Reviews
Title: Inotropic Therapies in Asphyxiated Neonates: The Clinical and Laboratory Facts
Volume: 5 Issue: 2
Author(s): Chloe Joynt and Po-Yin Cheung
Affiliation:
Keywords: Newborn, asphyxia, inotropes, catecholamines, blood pressure
Abstract: Asphyxiated neonates often have hypotension, shock and poor tissue perfusion. Various inotropic medications are commonly used to provide the cardiovascular support to improve the blood pressure and to treat shock. However, there is a paucity of literature on the systemic and regional hemodynamic effects of these inotropic medications in asphyxiated neonates, necessitating cautious translation of findings from other clinical populations and animal studies. This review discusses the current available information, from both clinical studies and animal models of neonatal asphyxia, on commonly used mediations including dopamine, dobutamine, epinephrine, milrinone, levosimendan and hydrocortisone.
Export Options
About this article
Cite this article as:
Joynt Chloe and Cheung Po-Yin, Inotropic Therapies in Asphyxiated Neonates: The Clinical and Laboratory Facts, Current Pediatric Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339609788185712
DOI https://dx.doi.org/10.2174/157339609788185712 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug
Current Diabetes Reviews Editorial: [Hot Topic: Antidotes and Rescue Therapies]
Current Pharmaceutical Biotechnology Update in the Management of Diastolic Heart Failure
Current Vascular Pharmacology Pathophysiology of Sepsis and Recent Patents on the Diagnosis, Treatment and Prophylaxis for Sepsis
Recent Patents on Inflammation & Allergy Drug Discovery Diet Bioactive Compounds: Implications for Oxidative Stress and Inflammation in the Vascular System
Endocrine, Metabolic & Immune Disorders - Drug Targets Endogenous Events Modulating Myogenic Regulation of Cerebrovascular Function
Current Vascular Pharmacology Anti-Vasopermeability Effects of PEDF in Retinal-Renal Disorders
Current Molecular Medicine Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty
Current Drug Targets Aortic Dissection: A Review of the Pathophysiology, Management and Prospective Advances
Current Cardiology Reviews Hypertension in Chronic Kidney Disease: Novel Insights
Current Hypertension Reviews Role of Vascular Nitric Oxide in Experimental Liver Cirrhosis
Current Vascular Pharmacology Melphalan in Regional Chemotherapy for Locally Recurrent Metastatic Melanoma
Current Topics in Medicinal Chemistry Adverse Drug Reactions in Critical Care Settings: A Systematic Review
Current Drug Safety Clinical Trials for Acute Kidney Injury: Design Challenges and Possible Solutions
Current Drug Targets Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn
Current Respiratory Medicine Reviews Pathophysiology and Pharmacologic Treatment of Venous Thromboembolism
Current Drug Targets Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways
Current Diabetes Reviews Taste and Hypertension in Humans: Targeting Cardiovascular Disease
Current Pharmaceutical Design Targeting CFTR: How to Treat Cystic Fibrosis by CFTR-Repairing Therapies
Current Drug Targets